Skip to main content
SpringerLink
Log in

Is the current standard therapy for hepatitis C of peginterferon and ribavirin an option for patients coinfected with HIV?

  • Practice Point
  • Published:

From Nature Clinical Practice Gastroenterology & Hepatology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sulkowski MS and Thomas DL (2003) Hepatitis C in the HIV-infected person. Ann Intern Med 138: 197–207

    Article  Google Scholar 

  2. Landau A et al. (2001) Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients. AIDS 15: 2149–2155

    Article  CAS  Google Scholar 

  3. Manns MP et al. (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358: 958–965

    Article  CAS  Google Scholar 

  4. Fried MW et al. (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347: 975–982

    Article  CAS  Google Scholar 

  5. Chung RT et al. (2004) Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 351: 451–459

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Minal Chande, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Director, GI/Hepatology Research at Duke University Medical Center, Durham, NC, USA

    John McHutchison

  2. Postdoctoral Hepatology Research Fellow, Duke Clinical Research Institute, Duke University, NC, USA

    Amany Zekry

Authors
  1. John McHutchison
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amany Zekry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John McHutchison.

Glossary

HCV GENOTYPES

Genomic variation in HCV, determined by sequencing

NEUTROPENIA

An absolute neutrophil count below 2000 per cubic millimeter

THROMBOCYTOPENIA

Low platelet count (normal platelet count is between 150,000–450,000 platelets per cubic millimeter)

APRICOT TRIAL

AIDS Pegasys Ribavirin International Coinfection Trial

ACTG A5071

AIDS Clinical Trials Group A5071 Study Team

Rights and permissions

Reprints and permissions

About this article

Cite this article

McHutchison, J., Zekry, A. Is the current standard therapy for hepatitis C of peginterferon and ribavirin an option for patients coinfected with HIV?. Nat Rev Gastroenterol Hepatol 1, 70–71 (2004). https://doi.org/10.1038/ncpgasthep0050

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0050

  • Springer Nature Limited

Search

Navigation